Total Payments
$7,499
2024 Payments
$482.94
Companies
51
Transactions
360
Payment Breakdown by Category
Food & Beverage$7,488 (99.8%)
Education$11.31 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,488 | 359 | 99.8% |
| Education | $11.31 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $971.00 | 29 | $0 (2020) |
| ABBVIE INC. | $662.01 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $491.54 | 19 | $0 (2024) |
| PFIZER INC. | $485.44 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $425.52 | 28 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $422.20 | 12 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $407.08 | 5 | $0 (2019) |
| Amgen Inc. | $303.70 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $284.13 | 16 | $0 (2024) |
| Novo Nordisk Inc | $267.33 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $482.94 | 25 | GlaxoSmithKline, LLC. ($80.05) |
| 2023 | $628.10 | 35 | GlaxoSmithKline, LLC. ($77.39) |
| 2022 | $616.72 | 34 | ABBVIE INC. ($259.08) |
| 2021 | $683.24 | 45 | AbbVie Inc. ($252.01) |
| 2020 | $770.41 | 41 | Allergan, Inc. ($187.61) |
| 2019 | $1,774 | 59 | Allergan Inc. ($662.00) |
| 2018 | $1,394 | 58 | E.R. Squibb & Sons, L.L.C. ($287.19) |
| 2017 | $1,150 | 63 | Valeant Pharmaceuticals North America LLC ($155.69) |
All Payment Transactions
360 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Vaccines | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: VACCINES | ||||||
| 08/14/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $55.22 | General |
| Category: Coronary | ||||||
| 08/14/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $13.60 | General |
| Category: Coronary | ||||||
| 08/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Oncology | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation | ||||||
| 06/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Biological | ||||||
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: VACCINE | ||||||
| 04/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: RESPIRATORY | ||||||
| 04/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Inflammation | ||||||
| 03/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: VACCINES | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Inflammation | ||||||
| 01/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Cardio-renal | ||||||
| 01/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
About Dr. Max Scheer, MD
Dr. Max Scheer, MD is a Internal Medicine healthcare provider based in Woodmere, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134298789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Max Scheer, MD has received a total of $7,499 in payments from pharmaceutical and medical device companies, with $482.94 received in 2024. These payments were reported across 360 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($7,488).
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Woodmere, NY
- Active Since 11/07/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134298789
Products in Payments
- ELIQUIS (Drug) $507.32
- PRALUENT (Drug) $422.20
- VRAYLAR (Drug) $395.41
- LINZESS (Drug) $360.15
- UBRELVY (Drug) $286.68
- XIFAXAN (Drug) $266.17
- BEVESPI AEROSPHERE (Drug) $245.50
- JANUVIA (Drug) $199.72
- ENTRESTO (Drug) $192.73
- FARXIGA (Drug) $183.57
- Xofluza (Drug) $166.48
- ZENPEP (Drug) $147.92
- Vascepa (Drug) $147.34
- Ozempic (Drug) $138.35
- Otezla (Drug) $137.86
- SYNTHROID (Drug) $130.95
- NEXLETOL (Drug) $126.82
- PRALUENT ALIROCUMAB INJECTION (Biological) $125.00
- XARELTO (Drug) $122.59
- CHANTIX (Drug) $119.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Woodmere
Michael Levine, Md, MD
Internal Medicine — Payments: $5,033
Internal Medicine $5,033
Steven Greenstein, Md, MD
Internal Medicine — Payments: $2,775
Internal Medicine $2,775
Dr. Alexander Lock, D.o, D.O
Internal Medicine — Payments: $283.55
Internal Medicine $283.55
Oluwaseun Opelami, M.d, M.D
Internal Medicine — Payments: $145.36
Internal Medicine $145.36
Ralph Iorio, M.d, M.D
Internal Medicine — Payments: $33.10
Internal Medicine $33.10
Sidney Jakubovics, M.d, M.D
Internal Medicine
Internal Medicine